Opdivo 240 MG/24 ML vial 24ML
Ended Awarded Last action
- Contract number
- SPE2DR26F0ZW3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,110
Award facts
- Contract value 100% obligated
- $33,109.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 13, 2026, the Defense Logistics Agency awarded a delivery order valued at $33,109.92 to AmerisourceBergen Drug Corp for the supply of OPDIVO 240 mg/24 ml vials. This firm fixed-price, non-set-aside contract will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of February 4, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving the federal healthcare supply chain. The delivery order is issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical, which is valued at up to $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
This award exemplifies the Defense Logistics Agency's approach to securing critical oncology medications through established pharmaceutical prime vendor relationships. OPDIVO (nivolumab) is an immuno-oncology drug essential for military treatment facilities and veteran healthcare programs. The non-competitive nature of this delivery order, issued against an existing indefinite delivery vehicle, reflects AmerisourceBergen's established capability to meet federal procurement requirements and its role as a key supplier within the DLA's Medical Supply Chain, which distributes pharmaceutical products across the Department of Defense's global healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F0ZW3?
SPE2DR26F0ZW3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F0ZW3 worth?
The government has obligated $33,110 on SPE2DR26F0ZW3.
Is contract SPE2DR26F0ZW3 an order under another contract?
Yes. SPE2DR26F0ZW3 is a delivery order under SPE2DR25D1205, an indefinite delivery contract.
Was contract SPE2DR26F0ZW3 competed?
The extent of competition for SPE2DR26F0ZW3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award